S&P Futures
4,586.50 -14.25 (-0.31%) Dow Futures
36,231.00 -72.00 (-0.20%) Nasdaq Futures
15,957.50 -66.25 (-0.41%) Russell 2000 Futures
1,876.00 +10.30 (+0.55%) Crude Oil
73.53 -0.54 (-0.73%) Gold
2,090.10 +0.40 (+0.02%)
electroCore, Inc. (ECOR)
- GlobeNewswire
Dr. Peter Staats to Host Analyst Day on the Science Behind gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) on Tuesday, November 21, 2023
ROCKAWAY, N.J., Nov. 15, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the Company’s Chief Medical Officer, Dr. Peter Staats will host an analyst day entitled “Accessing the Power of Vagus Nerve Stimulation with gammaCore™” on November 21, 2023 at 1:30pm EST. The webinar will cover the nVNS mechanism of action and potential pipeline of indications using the company’s proprietary nVNS technology plat
- Insider Monkey
electroCore, Inc. (NASDAQ:ECOR) Q3 2023 Earnings Call Transcript
electroCore, Inc. (NASDAQ:ECOR) Q3 2023 Earnings Call Transcript November 8, 2023 electroCore, Inc. misses on earnings expectations. Reported EPS is $-0.68 EPS, expectations were $-0.64. Operator: Greetings, and welcome to the electroCore Third Quarter 2023 Earnings Conference Call. At this time, all participants on a listen only mode. Please make sure to mute yourself. A […]
- GuruFocus.com
electroCore Inc (ECOR) Reports Substantial Sales Growth in Q3 2023
Net Sales Surge by 128% Year-Over-Year; Company Raises Full-Year Revenue Guidance
